{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:04:01Z","timestamp":1784721841859,"version":"3.55.0"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,2,15]]},"DOI":"10.2169\/internalmedicine.0997-18","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T18:30:13Z","timestamp":1539714613000},"page":"535-539","source":"Crossref","is-referenced-by-count":8,"title":["Bisoprolol Successfully Improved the Intraventricular Pressure Gradient in a Patient with Midventricular Obstructive Hypertrophic Cardiomyopathy with an Apex Aneurysm due to Apical Myocardial Damage"],"prefix":"10.2169","volume":"58","author":[{"given":"Ayano","family":"Tezuka","sequence":"first","affiliation":[{"name":"Departments of Cardiovascular Medicine, Japanese Red Cross Kagoshima Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjuro","family":"Higo","sequence":"additional","affiliation":[{"name":"Departments of Cardiovascular Medicine, Japanese Red Cross Kagoshima Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Nakamukae","sequence":"additional","affiliation":[{"name":"Departments of Clinical Laboratory Unit, Japanese Red Cross Kagoshima Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanae","family":"Nishihara","sequence":"additional","affiliation":[{"name":"Departments of Clinical Laboratory Unit, Japanese Red Cross Kagoshima Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Kamikawa","sequence":"additional","affiliation":[{"name":"Departments of Clinical Laboratory Unit, Japanese Red Cross Kagoshima Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Shimofuku","sequence":"additional","affiliation":[{"name":"Departments of Clinical Laboratory Unit, Japanese Red Cross Kagoshima Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Kawazoe","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery, Japanese Red Cross Kagoshima Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Ohishi","sequence":"additional","affiliation":[{"name":"Departments of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Parato VM, Antoncecchi V, Sozzi F, et al. Echocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathy. Cardiovasc Ultrasound 14: 30, 2016.","DOI":"10.1186\/s12947-016-0072-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35: 2733-2779, 2014.","DOI":"10.1093\/eurheartj\/ehu284"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Minami Y, Kajimoto K, Terajima Y, et al. Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 57: 2346-2355, 2011.","DOI":"10.1016\/j.jacc.2011.02.033"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Efthimiadis GK, Pagourelias ED, Parcharidou D, et al. Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction. Circ J 77: 2366-2374, 2013.","DOI":"10.1253\/circj.CJ-12-1561"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Hamada M, Shigematsu Y, Ohshima K, et al. Diagnostic usefulness of carotid pulse tracing in patients with hypertrophic obstructive cardiomyopathy due to midventricular obstruction: a comparison with idiopathic hypertrophic subaortic stenosis. Chest 124: 1275-1283, 2003.","DOI":"10.1378\/chest.124.4.1275"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nakamura T, Matsubara K, Furukawa K, et al. Diastolic paradoxic jet flow in patients with hypertrophic cardiomyopathy: evidence of concealed apical asynergy with cavity obliteration. J Am Coll Cardiol 19: 516-524, 1992.","DOI":"10.1016\/S0735-1097(10)80264-5"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Nishikawa N, Masuyama T, Yamamoto K, et al. Drug-induced changes in paradoxic jet flow in a patient with hypertrophic cardiomyopathy with midventricular obstruction. Shinzo 25: 1215-1219, 1993 (in Japanese).","DOI":"10.11281\/shinzo1969.25.10_1215"},{"key":"8","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/01.CIR.92.7.1680","volume":"92","author":"ED Wigle","year":"1995","unstructured":"8. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation 92: 1680-1692, 1995.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ammirati E, Contri R, Coppini R, Cecchi F, Frigerio M, Olivotto I. Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives. Eur J Heart Fail 18: 1106-1118, 2016.","DOI":"10.1002\/ejhf.541"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hamada M, Ikeda S, Shigematsu Y. Advances in medical treatment of hypertrophic cardiomyopathy. J Cardiol 64: 1-10, 2014.","DOI":"10.1016\/j.jjcc.2014.02.022"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Harada K, Shimizu T, Sugishita Y, et al. Hypertrophic cardiomyopathy with midventricular obstruction and apical aneurysm: a case report. Jpn Circ J 65: 915-919, 2001.","DOI":"10.1253\/jcj.65.915"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kaku B. Intra-cardiac thrombus resolution after anti-coagulation therapy with dabigatran in a patient with mid-ventricular obstructive hypertrophic cardiomyopathy: a case report. J Med Case Rep 7: 238, 2013.","DOI":"10.1186\/1752-1947-7-238"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Saba SG, Ertel AW, Siegenthaler M, et al. Hemodynamic consequences of hypertrophic cardiomyopathy with midventricular obstruction: apical aneurysm and thrombus formation. J Gen Pract (Los Angel) 2: 161, 2014.","DOI":"10.4172\/2329-9126.1000161"},{"key":"14","unstructured":"14. Sato Y, Matsumoto N, Matsuo S, Yoda S, Kunimoto S, Saito S. Mid-ventricular hypertrophic obstructive cardiomyopathy presenting with acute myocardial infarction. Tex Heart Inst J 34: 475-478, 2007."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sato Y, Matsumoto N, Matsuo S, et al. Mid-ventricular obstructive hypertrophic cardiomyopathy associated with an apical aneurysm: evaluation of possible causes of aneurysm formation. Yonsei Med J 48: 879-882, 2007.","DOI":"10.3349\/ymj.2007.48.5.879"},{"key":"16","unstructured":"16. Kiyooka T, Satoh Y. Mid-ventricular obstructive hypertrophic cardiomyopathy with an apical aneurysm caused by vasospastic angina. Tokai J Exp Clin Med 39: 29-33, 2014."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hanaoka Y, Misumi I, Rokutanda T, et al. Simultaneous pressure recording in mid-ventricular obstructive hypertrophic cardiomyopathy. Intern Med 51: 387-390, 2012.","DOI":"10.2169\/internalmedicine.51.6542"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Watanabe H, Kibira S, Saito T, et al. Beneficial effect of dual-chamber pacing for a left mid-ventricular obstruction with apical aneurysm. Circ J 66: 981-984, 2002.","DOI":"10.1253\/circj.66.981"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Tengiz I, Ercan E, Alioglu E, Turk UO. Percutaneous septal ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy: a case report. BMC Cardiovasc Disord 6: 15, 2006.","DOI":"10.1186\/1471-2261-6-15"},{"key":"20","unstructured":"20. Aoki M, Uekita K, Obata H, Makiguchi N, Mitsuoka T, Kikuchi K. Assessment of pathophysiology based on the left ventricular shape in five patients with midventricular obstructive hypertrophic cardiomyopathy. J Cardiol 50: 29-38, 2007 (in Japanese, Abstract in English)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Fighali S, Krajcer Z, Edelman S, Leachman RD. Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: higher incidence in patients with midventricular obstruction. J Am Coll Cardiol 9: 288-294, 1987.","DOI":"10.1016\/S0735-1097(87)80377-7"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/4\/58_0997-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T23:45:01Z","timestamp":1550274301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/4\/58_0997-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,15]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0997-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,15]]}}}